SAMSHA Tribal Opioid Response Grant (TOR) FOA TI-18-016 CFDA 93.799 Project Name Marimn Health MAT Program
The Marimn Health MAT Program incorporates the addition of outpatient Medically Assisted Treatment (MAT) services on-site at Marimn Health to close significant gaps in service. This addition will enhance the effectiveness of our Substance Use Disorder (SUD) treatment options. The program will serve two groups. The first are those in our SUD (Recovery) Program. The second are those candidates for the Emerge Program, a recovery program for pregnant or postpartum women and their infants. The Marimn Health Behavioral Health Services Department provides substance abuse evaluation and American Society of Addiction Medicine (ASAM) Level .05, Level 1, and Level 2 treatment for patients of Marimn Health (MH). The goal of the MAT program is to enhance these services through a decrease in the expense of referrals for in-treatment services, and, an increase in the provision of MAT out-patient services on-site. Presently, Marimn Health offers Substance User Disorder (SUD) treatment and has a continuous (SUD) patient population of about 70 patients annually. At present, MH Behavioral Health Department collaborates with Kootenai Hospital in Coeur d’Alene, Idaho for substance use disorder treatment for pregnant women. Pregnant mothers struggling with substance abuse are referred to the Kootenai Hospital Emerge Program for intake. A provider from the hospital conducts intakes into the hospital program at Marimn Health approximately one day per week. Emerge helps new mothers overcome the challenges with chemical dependency recovery, pregnancy and parenting, as well as helps with connection to resources. Marimn Health presently offers intensive outpatient and individual counseling, prenatal care and other medical needs. Part of Marimn Health’s strategic plan is to accommodate new incoming clients of Emerge with the establishment of an outpatient Emerge Program on-site at Marimn Health. Implementation is underway. Because there are a number of infants and children affected by opioids or other drugs, the MAT program plans to incorporate treatment for this group during the second year of the Tribal Opioid Response (TOR) project period. In 2017, there were 18 infants born with neonatal abstinence syndrome. Strategic planning includes training specific to the provision of therapy for infants and children affected by neonatal abstinence syndrome. The Coeur d’Alene Tribe Benewah Medical Center dba Marimn Health is located on the Coeur d’Alene Tribal Reservation in Plummer, Idaho. It is a Federally Qualified Health Center (FQHC) serving both Native Americans and non-Natives. In 2017, 6,201 patients were served. Of that total, 3,212 were Native American/Alaska Native. With (TOR) funding, MH anticipates providing MAT services for 15 individuals during the first year of the award. In Year Two of the Project Period MH anticipates serving a total of 25 individuals. MH proposes serving 40 participants throughout the entire TOR Two Year Performance Period. Through outreach and prevention the program will serve 3,212 Native Americans annually and throughout the lifetime of the project. Establishing and implementing MAT is part of the strategic plan to provide on-site outpatient services in a culturally appropriate manner which is patient centered and evidence based. We anticipate a decrease of in-patient treatment costs, an increase in adherence to recommended therapies, an increase in patient population, and, an increase in successful transitions into full and productive lives through increased access to MAT services.